Command Medical Products Strengthens Market Position with IMATS Acquisition

Command Medical Products Expands Its Capabilities with IMATS Acquisition



Command Medical Products, a leading contract manufacturer in the medical device industry, announced its latest strategic move: the acquisition of Injection Moulding Tooling Services S.A. (IMATS). This company, based in Costa Rica, specializes in injection molding and tooling services, thus boosting Command's manufacturing prowess in a crucial segment of the medical device market.

Enhancing Manufacturing Capabilities



This acquisition is pivotal for Command Medical as it broadens the range of services offered to clients. The integration of IMATS allows Command to provide a seamless experience from component production to finished device assembly. The services now span tooling design, fabrication, injection molding, tube extrusion, RF welding, clean room assembly, and packaging. Such comprehensive offerings enable Command to cater to a wider array of customer needs, thereby enhancing its market competitiveness.

CEO Mike Fillion expressed enthusiasm about bringing IMATS into the Command family. He noted that IMATS's capabilities in injection molding complement Command's existing operations, which include extrusion, welding, and assembly processes. The synergy expected from this merger is anticipated to provide clients with a more integrated and efficient manufacturing solution.

IMATS: A Valuable Addition



IMATS operates out of a 32,000 square foot facility located in Costa Rica’s Free Trade Zone. It is recognized for its robust injection molding, pad printing, assembly, and packaging services. Furthermore, the company excels in injection mold tooling design and validation. With existing production capabilities that can potentially double, IMATS is well-positioned to meet the growing demands of the medical device industry.

Julian Emery, the founder and president of IMATS, highlighted the excitement within his team at the prospect of joining Command Medical. The collaboration is expected to propel IMATS into a new growth phase while maintaining its commitment to quality and responsive customer service—a hallmark of its operations.

A Broader Strategy for Growth



Founded in 1987 and headquartered in Ormond Beach, Florida, Command Medical is a player in the global landscape of medical devices, providing essential components and finished products for Original Equipment Manufacturers (OEMs). The company prides itself on a comprehensive suite of manufacturing services, all executed in environments that meet stringent regulatory standards, including ISO 13485 and FDA registration.

By acquiring IMATS, Command Medical not only strengthens its production capabilities but also sets a robust foundation for future growth and scalability in the medical device market. This strategic acquisition signifies Command Medical's commitment to enhancing its offerings and maintaining its edge in an increasingly competitive industry.

The backing of Argosy Healthcare Partners, a private equity firm specializing in healthcare, further emphasizes the confidence in Command Medical's trajectory. With a focus on partnering with founder-owned healthcare businesses, Argosy provides a platform for growth and innovation in the healthcare sector.

In conclusion, the integration of IMATS into Command Medical Products marks an exciting chapter not only for the companies involved but also for the stakeholders they serve. As the medical device market continues to evolve, partnerships like this one will be crucial for delivering quality and efficiency in medical manufacturing.

Topics Consumer Products & Retail)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.